Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Continued baricitinib treatment leads to significant scalp hair regrowth in severe alopecia areata patients.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

CaBP1 and CaBP2 are important for maintaining hearing by supporting continuous calcium currents and nerve signaling in the ear.

A preauricular crease is common in people with coronary artery disease.

Baricitinib significantly regrows hair in nasal, genital, and beard areas for severe alopecia areata.

The CRABP I gene in cashmere goats is highly conserved but has unique features at specific amino sites.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

DAB labeling effectively identifies collagen type III and PDGFR in horse skin, but may show false positives.

The hydrogel helps bone growth and healing in jaw and facial defects.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Baricitinib helps treat severe hair loss in people over 65.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Rabies virus was found in specific skin cells of rabid dogs' muzzles, suggesting these cells could help diagnose rabies.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

An epidermal cyst in the temporal bone can occur as a rare delayed complication after ear surgery.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

ILC1-like cells can cause alopecia areata by themselves.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Baricitinib may help treat frontal fibrosing alopecia and facial papules.

Aire mutation reduces alopecia areata, while Notch4 mutation prevents it in mice.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Baricitinib effectively treated hair loss and inflammation in a patient with alopecia areata and lichen planopilaris.

Squaric acid dibutylester helps hair growth by increasing certain immune cells in the skin.

The chitosan-peptide system helps cartilage regeneration using fat-derived cells.

Mutations in the AP1B1 gene cause a new syndrome with skin, hearing, and developmental issues.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

Overexpression of ALK2 in hair follicles disrupts skin development and slows wound healing.

Baricitinib is effective and safe for treating alopecia areata.